MoneyWorks4Me

Nectar Lifesciences informs about newspaper publication

20 Aug 2026 Evaluate

Nectar Lifesciences has informed that it enclosed newspaper publication of notice to the shareholders regarding 31st AGM of the Company to be held on Friday, September 18, 2026, through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM), and other information which have been published in the following newspapers: Business Standard (English- all edition) dated 20.08.2026 circulating in the whole or substantially the whole of India; and Desh Sewak (Punjabi) dated 20.08.2026 being published in language of the region where the registered office of the Company is situated.

The above information is a part of company’s filings submitted to BSE.  

Nectar Lifesciences Share Price

10.63 0.37 (3.61%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: